Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Future Science OA|January 25, 2017
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccineSatoshi Takashima, Yoshihiro Oka, Fumihiro Fujiki, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|August 26, 2017
Diagnostic Performance and Safety of Positron Emission Tomography Using <sup>18</sup>F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb TrialToshihiko Wakabayashi, Toshihiko Iuchi, Naohiro Tsuyuguchi, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2015
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological responseNaoya Hashimoto, Akihiro Tsuboi, Naoki Kagawa, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 4, 2017
Association between ABCG2 and SLCO1B1 polymorphisms and adverse drug reactions to regorafenib: a preliminary study
Akimitsu Maeda, Hitoshi Ando, Takashi Ura, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2024
Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumorSoyoko Morimoto, Yukie Tanaka, Jun Nakata, et al.
The Oncologist|September 12, 2024
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective studyAkinobu Nakata, Naoya Hashimoto, Yukiya Narita, et al.
Pageof 17